Harris Erik 4
4 · Inozyme Pharma, Inc. · Filed Oct 7, 2024
Insider Transaction Report
Form 4
Harris Erik
Director
Transactions
- Award
Stock Option (right to buy)
2024-10-03+56,000→ 56,000 totalExercise: $5.06Exp: 2034-10-02→ Common Stock (56,000 underlying)
Footnotes (1)
- [F1]The option was granted on October 3, 2024. The shares underlying the option are scheduled to vest in equal monthly installments from October 3, 2024 through October 3, 2027